rPogyny announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis, a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow of the American College of Obstetricians & Gynecologists, and a Menopause Society Certified Practitioner, and Columbia University’s Dr. Whitney Booker, a double-board certified physician in Obstetrics and Gynecology and Maternal-Fetal Medicine, to its Medical Advisory Board.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny’s Strong Results Overshadowed by ART Cycle Decline and Core Business Uncertainty
- Progyny price target lowered to $21 from $23 at Canaccord
- Progyny’s Cautious Outlook: Hold Rating Amid Market Uncertainty and Conservative Guidance
- Progyny, Inc. Earnings Call Highlights Growth and Challenges
- Progyny, Inc. Reports Strong Q1 2025 Results